$HALB William A. Hartman, Chairman, President & CE
Post# of 144482
(Total Views: 252)
Posted On: 12/23/2020 9:02:01 AM
$HALB William A. Hartman, Chairman, President & CEO, stated, "We believe having multiple antibodies available not only increases our product application options, but also their effectiveness, when used in combination. Mathematically speaking, if each is 90% effective independently, then, absent any interrelationship of the two applications, the combination should be 99% effective. In other words, the prospect of obtaining diagnostic test false positives or false negatives is substantially reduced when antibodies work in tandem. The same would be true with regard to the use of antibodies in combination as a therapeutic tool as well as their use as a prophylactic measure in a nasal spray."
The details of the Halberd-ASU research contract can be viewed here.
If you would like to be added to our email subscriber list, click here and submit the form.
For more information, please contact:
William A. Hartman
w.hartman@halberdcorporation.com;
support@halberdcorporation.com
www.halberdcorporation.com
Twitter:@HalberdC
https://www.otcmarkets.com/stock/HALB/news/Ha...?id=284407
The details of the Halberd-ASU research contract can be viewed here.
If you would like to be added to our email subscriber list, click here and submit the form.
For more information, please contact:
William A. Hartman
w.hartman@halberdcorporation.com;
support@halberdcorporation.com
www.halberdcorporation.com
Twitter:@HalberdC
https://www.otcmarkets.com/stock/HALB/news/Ha...?id=284407
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
Scroll down for more posts ▼